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Collagen Distribution in the Human
Vitreoretinal Interface
Theodorus L. Ponsioen,1,2 Marja J. A. van Luyn,2 Roelofje J. van der Worp,1,2
Jan C. van Meurs,3 Johanna M. M. Hooymans,1 and Leonoor I. Los1
PURPOSE. To evaluate the presence of collagen types I to VII, IX,
XI, and XVIII at the posterior pole, the equator and the pre-
equatorial area in human donor eyes, since collagens are im-
portant macromolecules that contribute to vitreoretinal adhe-
sion at the vitreoretinal interface.
METHODS. Freshly isolated human retinectomy samples from
the equator were used for reverse transcription–polymerase
chain reaction to detect mRNA of the above-mentioned
collagens. In addition, human donor eyes and equatorial
retinectomy samples were embedded in paraffin, stained
with antibodies against the collagens and evaluated by light
microscopy (LM).
RESULTS. Retinectomy samples expressed mRNA of all tested
collagen types. By LM, vitreous cortex was positive for collagen
types II, V, IX, and XI. In all three regions within the donor
eyes and in the retinectomy samples, the internal limiting
membrane (ILM) showed types IV, VI, and XVIII; the retinal
vasculature was positive for types I to VI and XVIII in most
specimens; and the retinal layers showed condensed spots of
type VII. In addition, type VII increased in density and in
distribution over the retinal layers toward the posterior pole.
CONCLUSIONS. Staining patterns of collagen types I to V, IX, XI,
and XVIII confirmed previous observations. Important new
findings include the presence of type VI in the ILM and type VII
in several layers of the retina. Both collagens can anchor matrix
components, and type VI could be involved in vitreoretinal
attachment. Furthermore, the presence of collagen mRNA in
human retinectomy samples may be an indication of postnatal
collagen production by retinal cells. (Invest Ophthalmol Vis
Sci. 2008;49:4089–4095) DOI:10.1167/iovs.07-1456
The vitreous body (or vitreous) of the human eye is thetransparent extracellular matrix (ECM) located between
the lens and the retina. It is the largest structure of the eye and
consists of 98% to 99% water and of just 0.1% macromolecules,
such as glycosaminoglycans (such as hyaluronan),1 proteo-
glycans,2,3 glycoproteins4 (such as opticin5,6), collagens,7–15
and noncollagenous structural proteins4,5,16,17 (e.g., fibril-
lin5). The most important macromolecules are the collagens,
which form a network of heterotypic fibrils (types II, V/XI,
and IX) and presumably maintain the gel structure.5,7,18,19
Collagens present in the vitreous are types II,7,8 V and
XI,9 –11 VI,11,20 and IX.8,10 –15
The vitreous cortex is situated against the internal limiting
membrane (ILM) of the retina. Strong vitreoretinal adhesions
have been described at the vitreous base,21 at the equator,22
over retinal blood vessels,23 at the optic disc,24,25 and at the
macula.24 Furthermore, morphologic studies have revealed a
regional variability in thickness of the ILM, consisting of an
increase in thickness from the vitreous base toward the mac-
ular area, with a thinning over the fovea, optic disc, and retinal
blood vessels.23,26–28 Finally, attachment plaques (i.e.,
hemidesmosomes) are present in the equator and absent from
the posterior pole, with the exception of the fovea.26 In the
vitreous base area, which is known for its very strong vitreo-
retinal attachments, direct insertions of vitreous fibrils into
Mu¨ller cells and/or into crypts between adjacent Mu¨ller cells
have been found.26,29,30 Immunohistochemical studies on ILM
composition have shown the presence of the noncollagenous
components laminin, fibronectin, proteoglycans, and several
glycoconjugates31,32 as well as collagen types I, IV, and XVIII
(Jerdan JA, et al. IOVS 1986;27:ARVO Abstract 230).33,34
In the adult human retina, the collagens that have been
described (starting from the photoreceptor layer to the ILM)
are types I to VI26,35–40 and XVIII.34 In retinas of nonpatho-
logic donor eyes, isolated deposits of type II collagen have
been found in the pre-equatorial and equatorial areas.26 In
several studies, type II was also present in retinal blood ves-
sels,36,38,40 although this finding was ambiguous.37 It is also
unclear whether there is preference for an anterior location, as
suggested in a histopathologic pilot study on inherited rheg-
matogenous retinal detachment.40 Collagen types I, III, IV, V,
VI, and XVIII have been described as components of retinal
vasculature.34–39
The present study focused on the presence and distribution
of collagen types I to VII, IX, XI, and XVIII in the vitreoretinal
interface at the pre-equatorial area, the equator, and the pos-
terior pole, by studying human donor eyes and human retinec-
tomy samples. The knowledge about the distribution of colla-
gens can be useful in understanding the (patho)physiology of a





Four fresh retinectomy samples (70, 74, 86, and 87 years) were ac-
quired from patients with exudative macular degeneration during a
surgical procedure in which a full-thickness healthy equatorial autolo-
gous retinal pigment epithelium (RPE) and choroid graft is transplanted
to the macular area and in which the retina of the graft is not used in
the procedure.41,42 Informed consent was obtained before surgery
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with the approval of the medical ethics committee in accordance with
the standards laid down in the 1964 Declaration of Helsinki. The
retinectomy samples were taken from the equatorial retina at the 12
o’clock position and were immediately put into lysis buffer (Qiagen,
Venlo, The Netherlands). Total RNA was extracted from the samples
(RNeasy Mini Kit; Qiagen), according to the manufacturer’s instruc-
tions. To eliminate DNA contamination, RNA samples were treated
with DNA-free DNase (Ambion, Austin, TX). RNA concentration and
purity were determined on a spectrophotometer (Nanodrop; Isogen,
Maarssen, The Netherlands) by calculating the ratio of optical density
at wavelengths of 260 and 280 nm. RNA (2 g) was reverse transcribed
into cDNA by using M-MuLV reverse transcriptase (MBI Fermentas, St.
Leon-Rot, Germany), according to the manufacturer’s protocol (total
reaction, 20 L).
For the PCR reaction, 1 L cDNA was added to 23 L master mix,
consisting of 2.5 L 10 PCR buffer, 2.5 L 2 mM dNTP mix, 1.5 L
25 mM MgCl2, 0.25 L (5 U/L) Taq DNA polymerase (MBI Fermen-
tas), and 16.25 L ultrapure water (Milli-Q; Millipore, Billerica, MA).
Finally, a total of 1 L of the two specific flanking primers (50 M) was
added (Table 1). The mixtures were initially denatured at 94°C for 5
minutes. The PCR consisted of 35 cycles in the following conditions:
denaturation at 94°C for 0.5 minute, annealing at 55°C (for collagen
types I, II, III, V, and IX) and 58°C (for types IV, VI, VII, XI, and XVIII)
for 1 minute, and an extension period at 72°C for 1 minute. These
cycles were followed by a final extension period of 10 minutes at 72°C.
PCR products were analyzed by agarose gel electrophoresis (1%) with
500 ng/mL ethidium bromide. Human GAPDH (glyceraldehyde-3-phos-
phate dehydrogenase) and -actin were used as internal positive con-
trol. No amplification was obtained from the water control (data not
shown).
Paraffin Embedding Procedure
Three human eyes (three donors; aged 44, 55, and 74 years) with no
known ophthalmic disorder were obtained from the Cornea Bank
(Amsterdam, The Netherlands). After removal of small parts of the
globe, the eyes were fixed by immersion within 36 hours postmortem
in 2% paraformaldehyde (PF; Polysciences Inc., Warrington, UK) in
phosphate-buffered saline (PBS) overnight at 4°C. To achieve good
penetration of the fixatives, the washing, dehydration, and infiltration
steps were facilitated by gently rotating the specimens. The eyes were
washed in PBS and dehydrated by graded ethanols (50%–100%). Fi-
nally, the specimens were embedded in paraffin. In addition, three
retinectomy samples of three patients (aged 74, 75, and 75 years) were
put into 2% PF immediately after surgical removal and embedded in
paraffin according to the same procedure.
Immunohistochemistry
The pre-equatorial area, the equator, and the posterior pole were
selected from the donor eyes (Fig. 1). Both the selected areas and the
equatorial retinectomy samples were cut in sections of 5-m thickness
and studied by light microscopy (LM). The slides were deparaffinized
by the addition of xylene followed by short hydration steps with
ethanols (100%–50%). After they were washed with demiwater, 1%
type XXIV protease (Sigma-Aldrich, St. Louis, MO) was added for 30
minutes. Sections were washed with PBS, and endogenous peroxidases
were blocked. Then, sections were exposed to PBS with 2% bovine
serum albumin (BSA; Sanquin, Amsterdam, The Netherlands) and 5%
serum of the producer of the secondary antibody at room temperature.
The primary antibody was diluted 1:50 in PBS with 1% BSA and added
for 1 hour. The primary antibodies included (1) rabbit polyclonal
antibodies against human collagen types I, III, V (Abcam, Cambridge,
UK) and XI (the kind gift of Julia Thom Oxford, Boise State University,
Boise, ID) and against endostatin, the product of the C-terminal of type
XVIII (Abcam); (2) biotinylated rabbit polyclonal antibody against hu-
man type VI (Abcam); (3) goat polyclonal antibodies against human
types II and IV (Southern Biotechnology Associates [SBA], Birmingham,
AL); and (4) mouse monoclonal antibodies against human types VII
(Abcam) and IX (US Biological, Swampscott, MA). After the sections
were washed, the peroxidized secondary antibody diluted to 1:100 in
PBS, 1% BSA, and 2% human serum was added for 1 hour at room
temperature. Secondary antibodies included goat- and swine-anti-rabbit
peroxidases (GARPO and SARPO; Dako, Glostrup, Denmark), a rabbit-
anti-goat peroxidase (RAGPO; Dako), and a rabbit-anti-mouse peroxi-
dase (RAMPO; Dako). For biotinylated anti-type VI collagen antibody, a
streptavidin peroxidase (SAPO; Dako) was used. After the sections
were washed with PBS, they were stained with 3-amino-9-ethylcarba-
zole (AEC; Sigma-Aldrich) and hematoxylin.
Negative controls specimens underwent the entire procedure, ex-
cept for the substitution of the primary antibody. Three human corneas
were used as positive control specimens for collagen types IV and VI
(not shown). As an extra control for collagen type VII, a different rabbit
polyclonal antibody against type VII (Calbiochem, Darmstadt, Ger-
many) was used to confirm the data of the mouse monoclonal antibody
against type VII.
Morphologic Analysis
The morphologic data were semiquantitatively analyzed as follows:
within each donor eye (n 3) the pre-equatorial area, the equator, and
the posterior pole were identified. One author (RJW) took pictures
from the collagen labeling in the three areas in the donor eyes and from
the retinectomy samples. All pictures were randomly and digitally
presented at the same magnification to two independent masked
observers (TLP and LIL). Collagen labeling intensity was defined on a




The retinectomy samples expressed mRNA of all tested colla-
gen types (Fig. 2). Amplimers were seen at the expected
positions: COL1A1 at 254 bp, COL2A1 at 419 bp, COL3A1 at
369 bp, COL4A2 at 648 bp, COL5A1 at 454 bp, COL6A1 at 342
TABLE 1. Primers Used in the RT-PCR Analyses
Collagen Forward Primer: 533 Reverse Primer: 533 Size (bp)
COL1A1 TCG GCG AGA GCA TGA CCG ATG GAT GAC GCT GTA GGT GAA GCG GCT GTT 254
COL2A1 GTG GAA GAG TGG AGA CTA CTG TGT ACG TGA ACC TGC TAT TG 419
COL3A1 ACC GAT GAG ATT ATG ACT TCA CT CTG CAC ATC AAG GAC ATC TTC AG 369
COL4A2 ATC GGC TAC CTC CTG GTG AA GCT GAT GTG TGT GCG GAT GA 648
COL5A1 GAC TAC GCG GAC GGC ATG GAA CCT GCC AGG CCA CTG ACT GGT A 454
COL6A1 GGA GCT CAA GGA AGC CAT CAA G TCC TCC AGC AGC TCT GCA TAG T 342
COL7A1 CCG AGG ACG AGA TGG TGA AGT TG CTG GCT CCA GGT CCT GTG TCT AC 261
COL9A1 GCC TCT GGT GAA GAA GGT GAA TGC TGA TCT GTC GGT GCT CTA 245
COL11A1 CAG CAG GCT CGG ATT GCT CTG A GGC CAT CTA CAC CTG CCA TAC C 460
COL18A1 TCT ACG TGG ACT GTG AGG AGT T CTG CTC CTC GAC TTC TCC ACT T 380
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bp, COL7A1 at 261 bp, COL9A1 at 245 bp, COL11A1 at 460 bp,
and COL18A1 at 380 bp.
Light Microscopy
General Observations. Cross-sections and longitudinal
sections through donor eyes revealed that in each eye at least
part of the retina with the pigment epithelium had detached
from the choroid and sclera, probably as a result of the em-
bedding procedure. Sections through the retinectomy samples
showed no adherent vitreous because of the preceding vitrec-
tomy. In addition, the retinectomy samples contained no frag-
ments of the RPE layer. The judgments of the masked observers
were very similar in positive or negative scores, but showed
differences in the intensity of positivity (weak or strong). Since
quantitative results on immunohistochemical pictures ap-
peared less reliable, we used only positive or negative scores in
our results. In the cases in which the pre-equatorial area, the
equator, and the posterior pole stained positive or negative,
the intervening areas (not shown) were similarly stained.
Vitreoretinal Interface. The vitreoretinal interface is the
area of contact between the vitreous body and the retina. The
vitreous cortex when present was clearly positive for type II
collagen (Fig. 3B) and variably for types V, IX, and XI (Figs. 3E,
3G, 3H). The vitreous cortex showed no staining with the
antibody against type VI (Fig. 3F). The ILM was clearly positive
for types IV, VI, and XVIII in all three regions (Figs. 3D, 3F, 3I).
The staining patterns of types IV and VI at the ILM were the
same. In the case of type II, the ILM was not discernible as a
separate entity from the vitreous cortex (Figs. 3B, 3D). It was
observable only at places with a local vitreous detachment. The
retinectomy samples confirmed the presence of collagen types
IV and VI and the absence of type II in the ILM (not shown).
Human corneas stained specifically for types IV and VI (data
not shown).43
Retinal Blood Vessels. In almost all retinal layers and in all
three regions, small and large blood vessels were present. In
the donor eyes, blood vessels were strongly positive for colla-
gen types IV and VI and positive for types I, II, III, and XVIII
and for type V in two eyes (55 and 74 years; Figs. 3A–F, 3I).
However, type IX collagen was found only in the pre-equatorial
area, and the equator in two eyes (74 and 55 years, respec-
tively; Fig. 3G). The results of the retinectomy samples were
very similar, except for type IX, which was not detected.
Retina from the Photoreceptor Layer to the ILM. In all
three donor eyes, both antibodies against type VII collagen
(Fig. 4) showed multiple, positive, and circular spots occasion-
ally in the nerve fiber layer (NFL), ganglion cell layer (GCL),
inner plexiform layer (IPL), and inner nuclear layer (INL).
Besides the circular spots, dotted spots positive for type VII
were found more often in the vicinity of a nucleus. An obvious
finding was the increase in the amount as well as the spread
over the retinal layers of type VII–positive spots toward the
posterior pole (Figs. 4A–C). In the 69-year-old donor eye, type
XI collagen was faintly present in the GCL in the posterior pole
and the equator (Fig. 3H).
In the retinectomy samples, type VII collagen was found in
a spot-like configuration variably in the NFL, GCL, IPL, INL,
outer plexiform layer (OPL), and outer nuclear layer (ONL).
DISCUSSION
By immunohistochemical staining and LM evaluation, we de-
tected the collagens of interest. Our interest was primarily in
collagens with a potential role in vitreoretinal adhesion. These
can be subdivided into those collagens present both in the
vitreous cortex and the retina (such as collagen types II, V, VI,
and XVIII) and collagens which in other tissues are known to
mediate anchoring of one tissue structure to another (e.g., type
VII). New findings in this study are that type VI is located in the
ILM (previously only described in retinal blood vessels)38,44
and that type VII is widely distributed in several retina layers
with increasing density from the pre-equatorial area toward the
posterior pole. Furthermore, type II was present in human
retinal vasculature and was probably absent from the ILM. In
addition, previous published observations on collagen distribu-
tion in the vitreous and retina were confirmed.
In retinectomy samples, mRNA of 1-chains from types I to
III, V to VII, IX, XI, and XVIII collagen and mRNA of 2-chain
from type IV collagen were found. The presence of collagen
mRNA in this equatorial part of the retina is an indication that
these collagens can be synthesized by cells present in the
sample (e.g., Mu¨ller glial and endothelial cells). Besides the
ciliary body, which is often indicated as a possible source of
ILM and vitreous collagens,45–48 equatorial retinal cells may be
able to synthesize vitreous and ILM collagens. A comment
should be made that only collagen types II, III, VII, and XVIII
consist of three identical procollagens (1), and thus other
FIGURE 1. Schematic overview of an eye. Boxes 1, 2, and 3 indicate
the pre-equatorial area, the equator, and the posterior pole, respec-
tively. Co, cornea; le, lens; sc, sclera; on, optic nerve; ch, choroid; re,
retina; os, ora serrata; vb, vitreous body.
FIGURE 2. RT-PCR on an equatorial
retinectomy specimen (74-year-old
patient). Left to right: bands indicat-
ing the positions of collagen types I,
II, III, IV, V, VI, VII, IX, XI, and XVIII.
Human -actin and GAPDH were
positive. Left: 100-bp DNA ladder.
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chains may be essential for types I, IV, V, VI, IX, and XI to build
up a functional triple helical molecule.35
As previously described, the vitreous cortex was positive
for collagen types II, V/XI, and IX.5 We did not find type VI
collagen in the vitreous cortex, although this collagen has been
reported to be present in the vitreous.20 The light microscopic
absence of type VI in the vitreous cortex and the variable
presence of type V, IX, and XI may be explained by the small
amount present or by a masked epitope. At the vitreoretinal
interface, it was impossible to distinguish between the vitreous
cortex and the ILM, sometimes making it difficult to determine
whether labeling was at the vitreous cortex, the ILM, or both.
The difficulty in discriminating both structures is a known
problem described in previous studies.33,49 Based on speci-
mens with a local vitreous detachment and on the retinectomy
samples after vitrectomy, we concluded that the ILM contained
collagen types IV, VI, and XVIII, but not type II.
Type VI collagen is essentially a glycoprotein that belongs to
the non–fibril-forming collagens and forms a (beaded) filamen-
tous network in most ECMs.50,51 It has a predominant role in
linking cells and matrix macromolecules.52,53 It has shown
specific interactions with (1) hyaluronan in calf skin, which is
interesting since vitreous is also rich in hyaluronan,54,55; (2)
the striated collagen fibers of the inner and outer layers of
Bruch’s39; (3) collagen types I, III, and V within the scleral and
the corneal stromal collagen network56–58; (4) type IV in
Bowman’s layer57,58; and (5) pericytes at the choroidal side of
the choriocapillaris.59 In human iris and ciliary body, type VI
was found in the direct vicinity of the basement membranes,
but not in the vicinity of the epithelial basement membranes of
the ciliary and iris muscle cells.60 From the present study,
based on the widespread presence of type VI throughout the
ILM, we conclude that the entire vitreous is probably sur-
rounded by this type of collagen, which thus could mediate an
overall anchoring between the ILM and vitreous cortex.
Type XVIII collagen (of which endostatin, a potent angio-
genesis inhibitor, is a proteolytically derived fragment) was
found in the ILM, as previously described.34,61 Based on mouse
FIGURE 3. Immunohistochemical analyses of the collagens at the equator of human donor eyes evaluated by LM. (A) Type I (55 years) was present
in the smaller and larger retinal blood vessels. (B) Type II (74 years) was found in the vitreous cortex and in retinal blood vessels. The ILM showed
no type II at the place where the vitreous body was detached from the retina (✽). (C) Type III (55 years) was visible in the retinal blood vessels.
(D) Type IV (74 years) was present in the ILM and retinal blood vessels. At the site of the local vitreous detachment (✽), the ILM remained positive
for type IV and the vitreous cortex did not stain. (E) Type V (55 years) was found in the retinal blood vessels and vitreous cortex. (F) Type VI (55
years) was clearly present in retinal blood vessels and in the ILM, whereas the vitreous cortex shows no staining. (G) In this section, type IX was
present in retinal vasculature and in the vitreous cortex (55 years). (H) Type XI (arrows) was faintly stained in the GCL in the posterior pole (69
years). (I) Type XVIII was present as a faint staining in the ILM (arrowheads) and retinal blood vessels (arrows; 55 years). Vb, vitreous body; re,
retina. Bars, 50 m.
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studies, its function may be twofold: (1) part of an anchoring
complex between the vitreous fibrillar collagens and the ILM,
and (2) responsibility for the disappearance of vitreous hyaloid
vasculature in the embryonic period.62 Thus, its presence
could theoretically be associated with a protection against PVD
or against vascular neovascularization. It would therefore be
interesting to study type XVIII collagen/endostatin on ageing
and in diseases characterized by retinal neovascularization.
Retinal blood vessels contained collagen types I to VI and
XVIII , whereas types V and IX were variably present, which is
largely in agreement with previous studies on human retinal
vasculature. Previous immunohistochemical studies did not
uniformly confirm the presence of types II and IX.34,35,37–39 In
our study, the presence of type IX was very variable and needs
further investigation. With regard to type II, one study37 ques-
tioned its presence, which could be explained by the used
antiserum, and another found only type II in the peripheral
vasculature.40 However, Western Blot analysis on bovine reti-
nal blood vessels confirmed the presence of types I to V, of
which types II and IV were prominently present.36
The presence of type II collagen is interesting in the light of
strong interconnections between vitreous and retinal vascula-
ture23 and the possible source of this collagen. As a conse-
quence of the strong connection, vitreous hemorrhage can
occur during a posterior vitreous detachment.63 The presence
of mRNA COL2A1 in freshly isolated human retina could indi-
cate the retina as a possible production place of type II. The
producing cell of type II has still to be established, but Mu¨ller
cells are good candidates, since they are attached to the retinal
vasculature and ILM64 and their end feet are closely related to
sublaminar intraretinal type II collagen.33
Surprisingly, we found a condensed appearance of type VII
collagen, an anchoring fibril, in the retina. The staining pattern,
consisting of dotted spots and larger globular structures in
multiple retina layers, differed clearly from the superficial lin-
ear staining pattern previously found by LM in other tissues
(e.g., cornea).65 The presence of type VII in the retina is a new
finding and it is as yet unknown whether it is located intra- or
extracellularly. As far as is known from other tissues (e.g., skin
and cornea),66 functional type VII collagen is an extracellular
matrix component; it is the primary structural element of
anchoring fibrils, and it forms anchoring plaques (connection
areas between several anchoring fibrils) together with type
IV.67 Because its staining pattern is at variance with patterns
found in other tissues, where it connects ectodermal and
mesodermal tissue components, its retinal function is not im-
mediately clear and has to be determined in future studies.
Collagen types VI, VII, and XVIII are all able to anchor
matrix components to each other. Their presence in the retina
and their functions suggest an involvement in the (posterior)
vitreoretinal attachment and thus also in the mechanism of
(posterior) vitreoretinal detachment. At the moment, several
types of enzymes (e.g., (micro)plasmin and collagenase) are
used to pharmacologically induce liquefaction and PVD in
humans and animals, both therapeutically and experimentally,
but in most cases the mechanism of action remains un-
clear.68–71 When we focus on collagens, we see that subtypes
of collagenases should be able to degrade specific collagens,71
nattokinase can hydrolyze vitreous collagen fibers,72 thrombin
and plasmin can cleave type V collagen,73 and exogenous
plasmin can activate matrix metalloproteinase-2,74 which is
capable of degrading types IV and VII.75 Care should be taken
when enzymes are used to induce liquefaction and PVD. Little
is known about their mechanism of action on the vitreoretinal
interface, and it is questionable whether the action of these
enzymes stops at the ILM.
The presently described distribution patterns of different col-
lagen types in the human vitreoretinal interface emphasize the
possible interactions between the vitreous cortex and retina.
Future research should determine the exact roles of the various
collagens in vitreoretinal adhesions and interface pathology, the
process resulting in PVD, and the potential effects of enzymatic
vitreolysis on the vitreoretinal interface and retina.
FIGURE 4. The distribution of type
VII collagen in the 74-year-old donor
eye (A–C) and in the equatorial reti-
nectomy sample (D) (results of the
mouse monoclonal antibody are
shown). In the pre-equatorial area
(A), type VII collagen was not found.
In the equator (B), it was visible as
small positive spots in the GCL and
IPL, whereas, in the posterior pole
(C), it was present in nerve fiber
layer, the GCL, the IPL, and the OPL.
Arrows: dotted aspect; arrowheads:
circular spots; inset: circular spots
(left) and dotted spots (right) posi-
tive for type VII collagen. In the
equatorial retinectomy sample (D),
type VII collagen was also found in
the OPL and ONL. Arrows: spots
with the dotted aspect; arrowheads:
circular spots. Vb, vitreous body; re,
retina. Bars, 50 m.
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